miR-129-3p controls centrosome number in metastatic prostate cancer cells by repressing CP110

por Bijnsdorp, Irene V., Hodzic, Jasmina, Lagerweij, Tonny, Westerman, Bart, Krijgsman, Oscar, Broeke, Jurjen, Verweij, Frederik, Nilsson, R. Jonas A., Rozendaal, Lawrence, van Beusechem, Victor W., van Moorselaar, Jeroen A., Wurdinger, Thomas, Geldof, Albert A.
Publicado 2016

Effectiveness, cost-utility and implementation of a decision aid for patients with localised prostate cancer and their partners: study protocol of a stepped-wedge cluster randomise...

por Al-Itejawi, Hoda H M, van Uden-Kraan, Cornelia F, van de Ven, Peter M, Coupé, Veerle M H, Vis, André N, Nieuwenhuijzen, Jakko A, van Moorselaar, Jeroen A, Verdonck-de Leeuw, Irma M
Publicado 2017

Treating Primary Node-Positive Prostate Cancer: A Scoping Review of Available Treatment Options

por Zuur, Lotte G., de Barros, Hilda A., van der Mijn, Koen J. C., Vis, André N., Bergman, Andries M., Pos, Floris J., van Moorselaar, Jeroen A., van der Poel, Henk G., Vogel, Wouter V., van Leeuwen, Pim J.
Publicado 2023

Estetrol Cotreatment of Androgen Deprivation Therapy in Infiltrating or Metastatic, Castration-sensitive Prostate Cancer: A Randomized, Double-blind, Phase II Trial (PCombi)

por Coelingh Bennink, Herjan J.T., van Moorselaar, Jeroen A., Crawford, E. David, Roos, Erik P.M., Somford, Diederik M., Roeleveld, Ton A., de Haan, Tjard D., van Melick, Harm H.E., Reisman, Yacov, Zimmerman, Yvette, van Osta, Gonnie, Krijgh, Jan, Shore, Neal D., Saad, Fred, Schally, Andrew V., Debruyne, Frans M.J.
Publicado 2021